Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Semler Scientific, Inc. Director's Dealing 2021

Oct 13, 2021

32857_dirs_2021-10-13_b5d464b1-e8fd-4f31-860d-0c0a39835a29.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Semler Scientific, Inc. (SMLR)
CIK: 0001554859
Period of Report: 2021-10-11

Reporting Person: Murphy-Chutorian Douglas (Director, Chief Executive Officer, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-10-11 Common Stock S 200 $126.6550 Disposed 27121 Indirect
2021-10-11 Common Stock S 620 $129.0841 Disposed 26501 Indirect
2021-10-11 Common Stock S 430 $129.9884 Disposed 26071 Indirect

Footnotes

F1: Shares sold pursuant to a 10b5-1 trading plan.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.61 to $126.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.

F3: Shares are held by the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which the Reporting Person is co-Trustee with his spouse.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.50 to $129.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $129.75 to $130.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.